Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus.
about
Belimumab in systemic lupus erythematosusB-cell survival factors in autoimmune rheumatic disordersAltered B cell signalling in autoimmunity.Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus.Violation of an evolutionarily conserved immunoglobulin diversity gene sequence preference promotes production of dsDNA-specific IgG antibodies.TGFβ activated kinase 1 (TAK1) at the crossroad of B cell receptor and Toll-like receptor 9 signaling pathways in human B cells.Autoregulatory function of interleukin-10-producing pre-naïve B cells is defective in systemic lupus erythematosusLow numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS studySerum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.B Cells, Antibodies, and More.Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness.Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus.Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): A systematic review.Metabolic abnormalities and oxidative stress in lupus.The quest for personalized B-cell depletion therapy in rheumatic disease.HM71224, a selective Bruton's tyrosine kinase inhibitor, attenuates the development of murine lupus.Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon ActivityTargeting the B-cell pathway in lupus nephritis: current evidence and future perspectives.
P2860
Q26778277-94C841E2-FD0B-427C-B467-3E6CC648D897Q26796484-52E15EAC-337E-430B-9B65-8BDA8A38BA01Q33924642-F640417A-FABD-4679-A9BA-A81E2225FA76Q35035048-C0425A88-4960-4DA9-B3D9-B7FE97ABCCB1Q35113415-680B2C9E-FC4B-4BB5-9019-E125DEA00FF7Q35163864-3BBB7BE6-F3D9-47A8-B29D-937BA89D076FQ35889002-33537AA2-EC88-4410-9994-A8FA73CC2E1CQ36027561-8FD3C991-B612-4526-A3DD-34B82A10036EQ36106681-4BF2BEA4-B2D2-4AC9-A4BA-A9CB0718F73BQ36432935-9253FA8C-7F62-41A3-9DED-A8357E2AF6DBQ37698526-5E80F011-473F-4898-AF09-C1899EB0407BQ38690330-4500D7D7-9CB4-4A02-8499-A01EA711A8F5Q39218839-53263EEE-FB1C-4768-8621-7F40FA68D213Q39364970-308A451A-D89C-4F68-B5F5-4D4C2B21FF92Q39390654-56FA6FFA-B0CE-46E2-B620-F6FFB7627815Q41482035-48AA89DD-470E-4D7E-89F6-348B31944701Q41670053-0A75CE14-AFE8-4E98-9D81-958422100D26Q41692822-033F27E5-2216-4FF2-8C61-E47958EFA1A1Q51345238-110F99CB-60F2-4EDB-81FB-88B7EDE97404
P2860
Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Elevated serum BAFF levels are ...... systemic lupus erythematosus.
@en
Elevated serum BAFF levels are ...... systemic lupus erythematosus.
@nl
type
label
Elevated serum BAFF levels are ...... systemic lupus erythematosus.
@en
Elevated serum BAFF levels are ...... systemic lupus erythematosus.
@nl
prefLabel
Elevated serum BAFF levels are ...... systemic lupus erythematosus.
@en
Elevated serum BAFF levels are ...... systemic lupus erythematosus.
@nl
P356
P1476
Elevated serum BAFF levels are ...... systemic lupus erythematosus.
@en
P2093
Lucy M Carter
P304
P356
10.1002/ART.38074
P577
2013-10-01T00:00:00Z